Parabilis Medicines, Inc. · NASDAQ:PBLS
Parabilis Medicines, Inc. shareholders
As of Sep 30, 2026, 123 institutions reported holding Parabilis Medicines, Inc., 89.0% of its shares. Largest: Ra Capital Management, L.P., Fidelity and ARCH Venture Management, LLC. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Parabilis Medicines, Inc. | Change | Filed |
|---|---|---|---|---|
| Ra Capital Management, L.P. | 29.2M | 23.6% | +245K | Nov 16, 2026 |
| Fidelity | 10.9M | 8.8% | +575K | Nov 10, 2026 |
| ARCH Venture Management, LLC | 6.41M | 5.2% | no change | Nov 16, 2026 |
| venBio Partners LLC | 5.27M | 4.3% | no change | Nov 16, 2026 |
| Alphabet Inc. | 4.92M | 4.0% | no change | Nov 5, 2026 |
| Nextech Invest Ltd. | 4.66M | 3.8% | no change | Nov 16, 2026 |
| Cormorant Asset Management, LP | 4.62M | 3.7% | no change | Nov 16, 2026 |
| Regeneron Pharmaceuticals, Inc. | 4.17M | 3.4% | no change | Nov 5, 2026 |
| Vanguard | 3.41M | 2.8% | +914K | Nov 16, 2026 |
| Janus Henderson | 3.28M | 2.6% | first report | Nov 16, 2026 |